R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
2015; Elsevier BV; Volume: 125; Issue: 9 Linguagem: Inglês
10.1182/blood-2014-10-604561
ISSN1528-0020
AutoresAntonio Omuro, Denise D. Correa, Lisa M. DeAngelis, Craig H. Moskowitz, Matthew J. Matasar, Thomas Kaley, Igor T. Gavrilovic, Craig Nolan, Elena Pentsova, Christian Grommes, Katherine S. Panageas, Raymond E. Baser, Géraldine Faivre, Lauren E. Abrey, Craig S. Sauter,
Tópico(s)Moyamoya disease diagnosis and treatment
ResumoKey Points We conducted a phase-2 study in newly diagnosed PCNSL utilizing R-MPV and HDC with ASCT. Excellent disease control and OS (2-year PFS: 79%) were observed, with an acceptable toxicity profile and minimal neurotoxicity.
Referência(s)